<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00995813</url>
  </required_header>
  <id_info>
    <org_study_id>RS_Rota_vaccine_if</org_study_id>
    <nct_id>NCT00995813</nct_id>
  </id_info>
  <brief_title>Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure</brief_title>
  <official_title>Pilot Study of the Safety and Immunogenicity of the Rotavirus Vaccine in Infants With Intestinal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thrasher Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Seattle Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and immune response of the rotavirus
      vaccine in infants who have undergone abdominal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The safety of the rotavirus vaccine in infants with intestinal failure is the primary outcome variable.</measure>
    <time_frame>1-12 weeks following vaccine administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome measure is the preliminary measurement of the immunogenicity of the rotavirus vaccine in infants with intestinal failure.</measure>
    <time_frame>1-12 weeks following vaccine administration</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">15</enrollment>
  <condition>Intestinal Failure</condition>
  <condition>Rotavirus Vaccines</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Rotarix</intervention_name>
    <description>A rotavirus vaccine (Rotarix) will be administered in two doses, 8 weeks apart, in infants between 6 and 14 weeks of age. The standard dosage is 1 mL administered orally or per gastrostomy tube.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants with one of the following diagnoses:

               -  necrotizing enterocolitis requiring operation;

               -  congenital atresia of the intestine;

               -  gastroschisis;

               -  midgut volvulus requiring bowel resection; or

               -  long-segment intestinal aganglionosis

          -  Minimum gestational age of 35 weeks at time of first vaccine dose

        Exclusion Criteria:

          -  immunocompromise secondary to HIV infection or immunodeficiency state

          -  active use of corticosteroid or other immunosuppressive agents

          -  active infection as defined by fever &gt; 38Â°C within 24 hours, positive blood culture
             within 7 days, or positive urine culture within 3 days of enrollment

          -  severe malnutrition as defined by serum albumin &lt; 2.0 mg/dL or serum prealbumin &lt; 6
             mg/dL.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Weeks</minimum_age>
    <maximum_age>14 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick J Javid, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's Hospital and The University of Washington</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon Horslen, M.B., ChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's Hospital and The University of Washington</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janet Englund, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's Hospital and The University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2009</study_first_submitted>
  <study_first_submitted_qc>October 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2009</study_first_posted>
  <last_update_submitted>November 17, 2015</last_update_submitted>
  <last_update_submitted_qc>November 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seattle Children's Hospital</investigator_affiliation>
    <investigator_full_name>Patrick Javid</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Intestinal failure</keyword>
  <keyword>Rotavirus vaccine</keyword>
  <keyword>Infants</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

